Name | CCR4 antagonist 2 |
---|
Description | CCR4 antagonist 2 (Compound 31) is a novel potent, orally bioavailable small molecule antagonists of CC chemokine receptor 4 (CCR4) that inhibits Treg trafficking into the Tumor Microenvironment without suppressing the number of Treg in healthy tissues.CCR4 antagonist 2 (Compound 31) exhibits IC50 values of Ca2+flux and (chemotaxis) CTX are 40 nM and 70 nM, respectively[1]. |
---|---|
Related Catalog | |
Target |
IC50: 40 nM (Ca2+flux); 70 nM (CTX) (CCR4 antagonist 2)[1] |
References |
Molecular Formula | C26H28Cl2N6O |
---|---|
Molecular Weight | 511.45 |